Loading clinical trials...
Loading clinical trials...
T. cruzi has been divided into two main lineages: T. cruzi I (TcI) and T. cruzi II (TcII, including all non-TcI). TcI is predominant in Mexico and Central America, while TcII (non-TcI) is predominant ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tulane University School of Public Health and Tropical Medicine
Collaborators
NCT06632600 · Chagas Disease
NCT04984265 · Ventricular Tachycardia, Chagas Disease, and more
NCT02625974 · Chagas Disease
NCT03981523 · Trypanosoma Cruzi Infection, Chagas Disease
NCT00123916 · Chagas Disease, Trypanosomiasis, and more
Tulane School of Public Health and Tropical Medicine
New Orleans, Louisiana
Institute for Clinical Effectiveness and Health Policy
Buenos Aires
Laboratory of Parasitology, Universite Libre de Bruxelles
Brussels
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions